Assuming the first $5m is added to revenue for the quarterly and hopefully included in cashflow. Then we will see some price action.
After years of burning money with little to show for it apart from a 2 year delayed FDA approval, you can understand why there is a little bitterness and disbelief that Lumos has finally turned around.
We are at the floor of that turnaround, and in time the wider market will see it as well.
LDX Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)